LAS VEGAS, Sept. 4, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE:GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced that, as of September 3, 2026, it held approximately $36 million in cash and restricted cash and approximately 215 Bitcoin. As of September 3, 2026, the Company's combined cash, restricted cash and Bitcoin holdings totaled approximately $53 million, based on a Bitcoin price of approximately $81,500, representing nearly 200% of the Company's equity market capitalization as of that date.Milton "Todd" Ault III, Executive Chairman
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Hyperscale Data Holds Approximately $53 Million in Cash, Restricted Cash and Bitcoin, Representing Nearly 200% of Recent Market Capitalization
- Brookfield Announces Intention to Redeem its Class A Preference Shares, Series 51 and 52
All amounts in Canadian dollars unless otherwise stated. BROOKFIELD, NEWS, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Brookfield Corporation ("Brookfield") (NYSE:BN, TSX:BN) today announced that it intends to redeem all of its Cumulative Redeemable Class A Preference Shares, Series 51 (the "Series 51 Shares") (TSX:BN) and all of its Cumulative Redeemable Class A Preference Shares, Series 52 (the "Series 52 Shares") (TSX:BN) for cash on November 1, 2026 (the "Redemption Date"). The redemption price for each Series 51 Share will be $22.44, together with all accrued and unpaid dividends up to but excluding the Redemption Date. The redemption price for each Series 52 Share will be $22.00. Holders of
- Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
Results from previously presented BIONETIC-TRA study demonstrate the safety and feasibility of the device via trans-radial approach Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it will showcase innovative technologies at CIRSE 2026 in Copenhagen, reinforcing its commitment to advancing innovation for healthcare providers. Among the featured technologies will be the Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System. This technology is supported by the previously presented BIONETIC-TRA study, an investigator-initiated study with a 30-day follow-up period, that evaluated the safety and feasibility of the Dynetic™-35 Balloon-Ex
- RTX's Pratt & Whitney invests $25 million to expand precision parts manufacturing in Niepołomice, Poland
Site will add more than 120 jobs and increase production capacity for commercial and military engine componentsNIEPOLOMICE, Poland, Sept. 4, 2026 /PRNewswire/ -- Pratt & Whitney, an RTX (NYSE:RTX) business, is investing $25 million (PLN 95 million) to expand its manufacturing facility in Niepołomice, Poland, which is dedicated to producing complex tubular assemblies for commercial and military engines. The expanded site is expected to become operational in 2028 creating more than 120 jobs and will help meet growing demand for commercial and military engines. The Niepołomice facility already provides precision components for multiple engine types, including the Pratt & Whitney GTF™ engine pow
- Immuron to launch PROIBS® in the United States
MELBOURNE, Australia, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN) is pleased to announce that it has executed an exclusive distribution agreement for PROIBS® in the United States with Calmino group AB. Immuron launched PROIBS® in Australia during FY26. The overall U.S. digestive/gut health supplement market is valued at $4.16 billion (Mordor Intelligence). Immuron is targeting a subset of this market with PROIBS®. PROIBS® is a medical device used for abdominal pain, bloating and unsettled bowel movements (diarrhoea and/or constipation). PROIBS® contains AVH200®, derived from the plant, Aloe barbadensis Mill. AVH200® has gel forming components which support
- Dorian LPG Ltd. Announces VLGC Newbuilding Contracts, Forward Chartering Estimates, and New Credit Facility
Dorian LPG Ltd. (NYSE:LPG) ("Dorian" or the "Company"), a leading owner and operator of modern very large gas carriers ("VLGCs"), today announced that it entered into an agreement with Hanwha Ocean to build three 90,000 cbm dual-fuel Panamax VLGCs for delivery in June, September, and December of 2030 for a total price of approximately $345 million. The new VLGCs feature dual-fuel engines capable of operating on LPG and conventional low-sulphur fuels, as well as a Shaft Generator system that enables onboard power generation during sea passages. Their hull forms and main engines are optimized to accommodate larger-diameter propellers and energy-saving devices around the propellers, enhancin
- Cheetah Mobile To Report Second Quarter 2026 Financial Results on September 11, 2026
BEIJING, Sept. 4, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE:CMCM), a China-based IT company with a commitment to AI innovation, today announced that it will report its financial results for the second quarter 2026 before the U.S. market opens on Friday, September 11, 2026. The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com.Cheetah Mobile's management will hold an earnings conference call at 11:30 AM on Friday, September 11, 2026, Beijing Time (11:30 PM on Thursday, September 10, 2026, U.S. Eastern Time).Participants may join the conference call through Tencent Meeting using either the meeting link
- Bilibili Inc. Announces Proposed Offerings of US$700 Million Convertible Senior Notes, Concurrent Equity Placement and Concurrent Share Repurchases
SHANGHAI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced the proposed offerings (the "Notes Offerings") of US$700 million in aggregate principal amount of convertible senior notes due 2031 (the "Notes"), subject to market conditions and other factors, including US$200 million of the principal amount of the Notes subscribed for in the Tencent Notes Subscription (as described below). The Notes are initially available only to non-U.S. persons that are "qualified institutional buyers" (as defined in Rule 144A under the Securities Act of 1933, as amended (
- ALP NAMED OFFICIAL NICOTINE POUCH PARTNER OF MATCHROOM BOXING
America's fastest-growing nicotine pouch brand makes its first major UK and Ireland play, landing category exclusivity across Matchroom Boxing's autumn schedule beginning at Croke Park on 5 September, 2026LONDON and DUBLIN, Sept. 4, 2026 /PRNewswire/ -- ALP, the fastest-growing nicotine pouch brand in the United States, has been named the Official Nicotine Pouch Partner of Matchroom Boxing – its first major partnership in the UK and Ireland as an initial salvo of the brand's push into European markets. Founded in late 2024 as a direct-to-consumer business with no retail distribution, ALP became the number one DTC nicotine pouch
- Teledyne Qioptiq Receives First Option from Germany for Additional PHOENIX-XR Cooled Thermal Weapon Sights Valued at More Than $21 Million
Framework agreement represents largest European weapon sight procurement in company history German Bundeswehr order builds on growing demand for advanced thermal weapon sights Teledyne Technologies Incorporated (NYSE:TDY) announced that Teledyne Qioptiq has received the first option from the German Bundeswehr for PHOENIX-XR cooled weapons sights valued at more than $21 million. This is part of the previously announced framework agreement between Germany and Teledyne Qioptiq valued at up to $175 million. Upon completion of this tranche, Teledyne Qioptiq will have delivered more than 1,000 PHOENIX-XR units to the German Ministry of Defence, reinforcing the company's position as Europe's l
- UMC Reports Sales for August 2026
United Microelectronics Corporation (NYSE:UMC, TWSE: 2303)) ("UMC"), today reported unaudited net sales for the month of August 2026. Revenues for August 2026 Period 2026 2025 Y/Y Change Y/Y (%) August 25,044,641 19,159,816 5,884,825 30.71% Jan.-Aug. 178,659,250 155,816,479 22,842,771 14.66% (*) All figures in thousands of New Taiwan Dollars (NT$), except for percentages. (**) All figures are consolidated Additional information about UMC is available on the web at https://www.umc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260
- BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
RRP Preferred for High-Field Demonstration and First-of-a-Kind Power Plant OpportunitiesBruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (NASDAQ:BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration to support the rapidly growing demand for superconducting materials and technologies required by next-generation magnetic confinement fusion power demonstration plant projects worldwide.The BEST-LUVATA collaboration aims to further strengthen and expand industrial readiness and availability of high-performance RRP superconductors to significantly upscale global manufacturing capacity, enhance supply
- Invest Acquisition Corporation Files Definitive Information Statement For Extension of Deadline to Complete Business Combination to December 17, 2029 With Redemption Deadline Set For 5:00 P.M. Eastern Time on SEPTEMBER 22, 2026
BOCA RATON, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Invest Acquisition Corporation (OTC:IVCB, IVCBU, IVCBW)) today announced it has filed a definitive information statement with the SEC extending the deadline to complete its initial business combination to December 17, 2029. An extraordinary general meeting will be held on September 24, 2026 in connection with the extension. Public shareholders have the right to redeem their Class A ordinary shares for a pro rata portion of the trust account; redemption requests must be submitted to the Company's transfer agent by 5:00 p.m. Eastern Time on September 22, 2026. Full details are available in the Company's information statement filed with th
- LGI Homes, Inc. Reports August 2026 Home Closings
THE WOODLANDS, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ:LGIH) today announced it closed 409 homes in August 2026, including 9 currently or previously leased single-family rental homes. This represents a 9.9% increase compared to 372 homes closed in August 2025. As of August 31, 2026, the Company had 153 active selling communities. About LGI Homes, Inc. Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. LGI Homes has closed over 80,000 homes since its founding in 2003 and has deliv
- KKR Invests in Malaysian Healthcare Platform Avisena Healthcare
KKR, a leading global investment firm, and Avisena Healthcare ("Avisena"), a Malaysian healthcare provider, today announced that funds managed by KKR have entered into a definitive agreement to make a minority investment in Avisena. The investment will support Avisena’s next phase of growth, including the expansion of multi-specialty offerings at Avisena’s flagship hospitals in Shah Alam, and the build-out of new greenfield hospitals within the Klang Valley. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260903337108/en/ Founded in 1996, Avisena has built a leading healthcare presence in Shah Alam and the wider Klang Valley, Mal
- Bluerock Private Real Estate Fund Announces Monthly Distribution for September 2026
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Bluerock Private Real Estate Fund (ticker: BPRE) today announced it will pay a cash distribution of $0.1371 per share for September 2026. The distribution will be paid to shareholders of record as of September 16, 2026, reflecting a 7.3% distribution rate on NAV as well as an annualized market distribution rate of approximately 13.8% and an annualized tax-equivalent distribution rate of 21.5%1, based on the BPRE closing price of $11.91 on September 3, 2026. The distribution will be made on the schedule below:Record Date9/16/26Ex-Dividend Date9/16/26Pay Date9/30/26Distribution$0.1371BPRE h
- DSS, Inc. Announces Launch of Proposed Public Offering
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that it has commenced a public offering to offer and sell shares of its Common Stock. All of the shares of Common Stock are being offered by the Company (the "Offering"). The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s Common Stock is trading on the NYSE American LLC under the symbol "DSS". The Offering is subject to market conditions, and there can be
- H World Group Limited Announces Proposed Offering of CNY-denominated Bonds
SINGAPORE and SHANGHAI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ:HTHT) ("H World" or the "Company," together with its subsidiaries, the "Group"), a key player in the global hotel industry, today announced that it proposes to offer CNY-denominated bonds (the "Bonds") in offshore transactions outside the United States to non-U.S. persons in reliance on Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act"), subject to market conditions and other factors (the "Bond Offering"). The principal amount, interest rates, maturity dates and other terms of the Bonds will be determined at the time of pricing of the Bond Offering. The Comp
- ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
- Provides a clinically meaningful impact on motor function and a favorable impact on other symptoms seen in AxD, an ultra-rare, progressive and often fatal neurological disorder - - Priority Review Voucher (PRV) awarded in conjunction with approval - - ZANVASTRO marks Ionis’ first independent launch from its industry-leading neurology pipeline and second independent launch this year - – Ionis to host webcast on Friday, Sept. 4 at 10:00 a.m. ET – Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen) for the treatment of Alexander disease (AxD) in pediatric and adult patients. ZANVASTRO is the
- Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
–4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with zorevunersen on top of standard of care anti-seizure medicines– –New data showed substantial reductions in the most severe seizure types, the leading risk factor for sudden unexpected death in epilepsy (SUDEP)– –Improvements in quality of life were demonstrated through 28 months of treatment– –Zorevunersen generally well tolerated, with some patients treated for more than 5 years– –Data from the global, pivotal Phase 3 EMPEROR study anticipated in Q3 2027 to complete the planned rolling U.S